{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T21:00:45Z","timestamp":1780347645184,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-025-05923-2","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T08:13:35Z","timestamp":1751616815000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Erythroderma as a presenting feature of dermatomyositis: case-based review"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3503-3043","authenticated-orcid":false,"given":"Shini","family":"Choubey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-6042","authenticated-orcid":false,"given":"Prakashini","family":"Mruthyunjaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4160-5722","authenticated-orcid":false,"given":"Chinmoy","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1358-1268","authenticated-orcid":false,"given":"Debasmita","family":"Behera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4631-311X","authenticated-orcid":false,"given":"Sakir","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"5923_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/0019-5154.48976","volume":"54","author":"C Okoduwa","year":"2009","unstructured":"Okoduwa C, Lambert WC, Schwartz RA et al (2009) Erythroderma: review of a potentially life-threatening dermatosis. Indian J Dermatol 54:1\u20136. https:\/\/doi.org\/10.4103\/0019-5154.48976","journal-title":"Indian J Dermatol"},{"key":"5923_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/s0190-9622(96)90496-x","volume":"35","author":"V Sigurdsson","year":"1996","unstructured":"Sigurdsson V, Toonstra J, Hezemans-Boer M, van Vloten WA (1996) Erythroderma. A clinical and follow-up study of 102 patients, with special emphasis on survival. J Am Acad Dermatol 35:53\u201357. https:\/\/doi.org\/10.1016\/s0190-9622(96)90496-x","journal-title":"J Am Acad Dermatol"},{"key":"5923_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.4103\/0378-6323.198434","volume":"83","author":"R Mathew","year":"2017","unstructured":"Mathew R, Sreedevan V (2017) Erythroderma: A clinicopathological study of 370 cases from a tertiary care center in Kerala. IJDVL 83:625. https:\/\/doi.org\/10.4103\/0378-6323.198434","journal-title":"IJDVL"},{"key":"5923_CR4","first-page":"38","volume":"63","author":"A Chaudhary","year":"1997","unstructured":"Chaudhary A, Gupte PD (1997) Erythroderma: a study of incidence and aetiopathogenesis. IJDVL 63:38","journal-title":"IJDVL"},{"key":"5923_CR5","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/ced.14625","volume":"46","author":"S Tso","year":"2021","unstructured":"Tso S, Satchwell F, Moiz H et al (2021) Erythroderma (exfoliative dermatitis). Part 1: underlying causes, clinical presentation and pathogenesis. Clin Exp Dermatol 46:1001\u20131010. https:\/\/doi.org\/10.1111\/ced.14625","journal-title":"Clin Exp Dermatol"},{"key":"5923_CR6","doi-asserted-by":"publisher","first-page":"9774","DOI":"10.1038\/s41598-020-66040-7","volume":"10","author":"D Miyashiro","year":"2020","unstructured":"Miyashiro D, Sanches JA (2020) Erythroderma: a prospective study of 309 patients followed for 12 years in a tertiary center. Sci Rep 10:9774. https:\/\/doi.org\/10.1038\/s41598-020-66040-7","journal-title":"Sci Rep"},{"key":"5923_CR7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.5021\/ad.2009.21.4.435","volume":"21","author":"SW Kim","year":"2009","unstructured":"Kim SW, Kang YS, Park SH et al (2009) A case of erythrodermic dermatomyositis associated with gastric Cancer. Ann Dermatol 21:435\u2013439. https:\/\/doi.org\/10.5021\/ad.2009.21.4.435","journal-title":"Ann Dermatol"},{"key":"5923_CR8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/s0733-8635(02)00015-3","volume":"20","author":"S Boyce","year":"2002","unstructured":"Boyce S, Harper J (2002) Paraneoplastic dermatoses. Dermatol Clin 20:523\u2013532. https:\/\/doi.org\/10.1016\/s0733-8635(02)00015-3","journal-title":"Dermatol Clin"},{"key":"5923_CR9","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/ue71ku","author":"D Lim","year":"2022","unstructured":"Lim D, Fiorentino D, Werth V (2022) Current concepts and advances in dermatomyositis: a dermatological perspective. Clin Exp Rheumatol. https:\/\/doi.org\/10.55563\/clinexprheumatol\/ue71ku","journal-title":"Clin Exp Rheumatol"},{"key":"5923_CR10","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1007\/s10067-021-05691-x","volume":"40","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Zimba O, Gasparyan AY (2021) COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol 40:2611\u20132619. https:\/\/doi.org\/10.1007\/s10067-021-05691-x","journal-title":"Clin Rheumatol"},{"key":"5923_CR11","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"5923_CR12","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s10067-017-3706-6","volume":"36","author":"KB Poulsen","year":"2017","unstructured":"Poulsen KB, Alexanderson H, Dalg\u00e5rd C et al (2017) Quality of life correlates with muscle strength in patients with dermato- or polymyositis. Clin Rheumatol 36:2289\u20132295. https:\/\/doi.org\/10.1007\/s10067-017-3706-6","journal-title":"Clin Rheumatol"},{"key":"5923_CR13","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M et al (2017) EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76:1955\u20131964. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"},{"key":"5923_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/art.40320","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M et al (2017) Arthritis Rheumatol. European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups, 69:2271\u20132282. https:\/\/doi.org\/10.1002\/art.40320."},{"key":"5923_CR15","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/0049-0172(90)90024-a","volume":"20","author":"G Ram\u00edrez","year":"1990","unstructured":"Ram\u00edrez G, Asherson RA, Khamashta MA et al (1990) Adult-onset polymyositis-dermatomyositis: description of 25 patients with emphasis on treatment. Semin Arthritis Rheum 20:114\u2013120. https:\/\/doi.org\/10.1016\/0049-0172(90)90024-a","journal-title":"Semin Arthritis Rheum"},{"key":"5923_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0190-9622(08)80580-4","volume":"26","author":"S Miyagawa","year":"1992","unstructured":"Miyagawa S, Okazaki A, Minowa R, Shirai T (1992) Dermatomyositis presenting as erythroderma. J Am Acad Dermatol 26:489\u2013490","journal-title":"J Am Acad Dermatol"},{"key":"5923_CR17","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0190-9622(98)70022-2","volume":"39","author":"HC Nousari","year":"1998","unstructured":"Nousari HC, Kimyai-Asadi A, Spegman DJ (1998) Paraneoplastic dermatomyositis presenting as erythroderma. J Am Acad Dermatol 39:653\u2013654. https:\/\/doi.org\/10.1016\/S0190-9622(98)70022-2","journal-title":"J Am Acad Dermatol"},{"key":"5923_CR18","first-page":"353","volume":"130","author":"A Maruani","year":"2003","unstructured":"Maruani A, Armingaud P, Nseir A et al (2003) [Erythroderma and multiple cutaneous necrosis revealing a dermatomyositis]. Ann Dermatol Venereol 130:353\u2013356","journal-title":"Ann Dermatol Venereol"},{"key":"5923_CR19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1365-2230.2007.02447.x","volume":"32","author":"ZH Liu","year":"2007","unstructured":"Liu ZH, Wang XD (2007) Acute-onset adult dermatomyositis presenting with erythroderma and diplopia. Clin Exp Dermatol 32:751\u2013752. https:\/\/doi.org\/10.1111\/j.1365-2230.2007.02447.x","journal-title":"Clin Exp Dermatol"},{"key":"5923_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13256-018-1618-y","volume":"12","author":"HMMTB Herath","year":"2018","unstructured":"Herath HMMTB, Keragala BSDP, Pahalagamage SP et al (2018) Erythroderma and extensive poikiloderma\u2013 a rare initial presentation of dermatomyositis: a case report. J Med Case Rep 12:83. https:\/\/doi.org\/10.1186\/s13256-018-1618-y","journal-title":"J Med Case Rep"},{"key":"5923_CR21","doi-asserted-by":"publisher","first-page":"2050313X1984517","DOI":"10.1177\/2050313X19845174","volume":"7","author":"AA Ali","year":"2019","unstructured":"Ali AA, Basharat P, Lovegrove F (2019) A dermatomyositis\/lichen planus overlap syndrome presenting with erythroderma: A case report. SAGE Open Med Case Rep 7:2050313X19845174. https:\/\/doi.org\/10.1177\/2050313X19845174","journal-title":"SAGE Open Med Case Rep"},{"key":"5923_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0002-9343(86)90036-7","volume":"80","author":"EJ Fudman","year":"1986","unstructured":"Fudman EJ, Schnitzer TJ (1986) Dermatomyositis without creatine kinase elevation. A poor prognostic sign. Am J Med 80:329\u2013332. https:\/\/doi.org\/10.1016\/0002-9343(86)90036-7","journal-title":"Am J Med"},{"key":"5923_CR23","doi-asserted-by":"publisher","first-page":"e232854","DOI":"10.1136\/bcr-2019-232854","volume":"13","author":"S Nagiah","year":"2020","unstructured":"Nagiah S, Saranapala DMM (2020) Severe proximal muscle weakness with normal CK as a presenting feature of ANCA-associated vasculitis. BMJ Case Rep 13:e232854. https:\/\/doi.org\/10.1136\/bcr-2019-232854","journal-title":"BMJ Case Rep"},{"key":"5923_CR24","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s10067-024-06873-z","volume":"43","author":"X Xing","year":"2024","unstructured":"Xing X, Gan Y, Mo W et al (2024) Clinical and immunological characteristics and prognosis of patients with autoantibody negative dermatomyositis: a case control study. Clin Rheumatol 43:1145\u20131154. https:\/\/doi.org\/10.1007\/s10067-024-06873-z","journal-title":"Clin Rheumatol"},{"key":"5923_CR25","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1097\/RHU.0000000000002043","volume":"30","author":"C-W Tseng","year":"2024","unstructured":"Tseng C-W, Satoh M, Hasegawa T et al (2024) Analytic and clinical validity of Myositis-Specific antibodies by Line-Blot immunoassay is essential. J Clin Rheumatol 30:e23\u2013e28. https:\/\/doi.org\/10.1097\/RHU.0000000000002043","journal-title":"J Clin Rheumatol"},{"key":"5923_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s12026-017-8974-3","volume":"66","author":"M Infantino","year":"2018","unstructured":"Infantino M, Palterer B, Biagiotti R et al (2018) Reflex testing of speckled cytoplasmic patterns observed in routine ANA HEp-2 indirect Immunofluorescence with a multiplex anti-synthetase dot-blot assay: a multicentric pilot study. Immunol Res 66:74\u201378. https:\/\/doi.org\/10.1007\/s12026-017-8974-3","journal-title":"Immunol Res"},{"key":"5923_CR27","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s12026-018-9006-7","volume":"66","author":"LK Peterson","year":"2018","unstructured":"Peterson LK, Jaskowski TD, La\u2019ulu SL, Tebo AE (2018) Antibodies to small ubiquitin-like modifier activating enzyme are associated with a diagnosis of dermatomyositis: results from an unselected cohort. Immunol Res 66:431\u2013436. https:\/\/doi.org\/10.1007\/s12026-018-9006-7","journal-title":"Immunol Res"},{"key":"5923_CR28","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s00296-024-05612-6","volume":"44","author":"D\u00dc Cansu","year":"2024","unstructured":"Cansu D\u00dc, Yildirim R, Uludo\u011fan BC et al (2024) Evaluation of the frequency and risk factors of spontaneous intramuscular hemorrhage associated with dermatomyositis. Rheumatol Int 44:1327\u20131335. https:\/\/doi.org\/10.1007\/s00296-024-05612-6","journal-title":"Rheumatol Int"},{"key":"5923_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00296-023-05475-3","volume":"44","author":"J Nossent","year":"2024","unstructured":"Nossent J, Keen H, Preen DB, Inderjeeth CA (2024) The spectrum of idiopathic inflammatory myopathies in Western australia: epidemiological characteristics and mortality over time. Rheumatol Int 44:329\u2013337. https:\/\/doi.org\/10.1007\/s00296-023-05475-3","journal-title":"Rheumatol Int"},{"key":"5923_CR30","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s00296-017-3658-9","volume":"37","author":"M Oztas","year":"2017","unstructured":"Oztas M, Ugurlu S, Aydin O (2017) Atorvastatin-induced dermatomyositis. Rheumatol Int 37:1217\u20131219. https:\/\/doi.org\/10.1007\/s00296-017-3658-9","journal-title":"Rheumatol Int"},{"key":"5923_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00296-017-3821-3","volume":"38","author":"IBP Borges","year":"2018","unstructured":"Borges IBP, Silva MG, Misse RG, Shinjo SK (2018) Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review. Rheumatol Int 38:293\u2013301. https:\/\/doi.org\/10.1007\/s00296-017-3821-3","journal-title":"Rheumatol Int"},{"key":"5923_CR32","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00296-021-04851-1","volume":"42","author":"C Akiyama","year":"2022","unstructured":"Akiyama C, Shirai T, Sato H et al (2022) Association of various myositis-specific autoantibodies with dermatomyositis and polymyositis triggered by pregnancy. Rheumatol Int 42:1271\u20131280. https:\/\/doi.org\/10.1007\/s00296-021-04851-1","journal-title":"Rheumatol Int"},{"key":"5923_CR33","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00296-021-05035-7","volume":"42","author":"RE Ruiz-Lozano","year":"2022","unstructured":"Ruiz-Lozano RE, Velazquez-Valenzuela F, Roman-Zamudio M et al (2022) Polymyositis and dermatomyositis: ocular manifestations and potential sight-threatening complications. Rheumatol Int 42:1119\u20131131. https:\/\/doi.org\/10.1007\/s00296-021-05035-7","journal-title":"Rheumatol Int"},{"key":"5923_CR34","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1007\/s00296-023-05428-w","volume":"43","author":"M Azzam","year":"2023","unstructured":"Azzam M, Awad A, Abugharbyeh A, Kahaleh B (2023) Myocarditis in connective tissue diseases: an often-overlooked clinical manifestation. Rheumatol Int 43:1983\u20131992. https:\/\/doi.org\/10.1007\/s00296-023-05428-w","journal-title":"Rheumatol Int"},{"key":"5923_CR35","doi-asserted-by":"publisher","first-page":"432","DOI":"10.21037\/atm-20-5215","volume":"9","author":"U Khanna","year":"2021","unstructured":"Khanna U, Galimberti F, Li Y, Fernandez AP (2021) Dermatomyositis and malignancy: should all patients with dermatomyositis undergo malignancy screening? Annals Translational Med 9:432\u2013432. https:\/\/doi.org\/10.21037\/atm-20-5215","journal-title":"Annals Translational Med"},{"key":"5923_CR36","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1046\/j.1365-2133.2001.04140.x","volume":"144","author":"YJ Chen","year":"2001","unstructured":"Chen YJ, Wu CY, Shen JL (2001) Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study. Br J Dermatol 144:825\u2013831. https:\/\/doi.org\/10.1046\/j.1365-2133.2001.04140.x","journal-title":"Br J Dermatol"},{"key":"5923_CR37","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/rheumatology\/keac115","volume":"61","author":"AGS Oldroyd","year":"2022","unstructured":"Oldroyd AGS, Lilleker JB, Amin T et al (2022) British society for rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy. Rheumatology 61:1760\u20131768. https:\/\/doi.org\/10.1093\/rheumatology\/keac115","journal-title":"Rheumatology"},{"key":"5923_CR38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00296-019-04467-6","volume":"40","author":"T Khoo","year":"2020","unstructured":"Khoo T, Limaye V (2020) Biologic therapy in the idiopathic inflammatory myopathies. Rheumatol Int 40:191\u2013205. https:\/\/doi.org\/10.1007\/s00296-019-04467-6","journal-title":"Rheumatol Int"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05923-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-05923-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05923-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T01:06:56Z","timestamp":1757207216000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-05923-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["5923"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-05923-2","relation":{"references":[{"id-type":"doi","id":"10.1002\/art.40320","asserted-by":"subject"}]},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"A written informed consent was obtained from the patient for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"164"}}